A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection
Public ClinicalTrials.gov record NCT04225923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection
Study identification
- NCT ID
- NCT04225923
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Nobelpharma
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- NPC-21 Low dose Drug
- NPC-21 High dose Drug
- NPC-21 Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 76 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2020
- Primary completion
- Nov 1, 2022
- Completion
- Feb 7, 2023
- Last update posted
- Jun 16, 2025
2020 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Scottsdale | Phoenix | Arizona | 85054 | — |
| California Institute of Renal Research | La Mesa | California | 91942 | — |
| Piedmont Healthcare | Atlanta | Georgia | 30309 | — |
| Augusta University Medical Center | Augusta | Georgia | 30912 | — |
| University of Michigan | Ann Arbor | Michigan | 48084 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| The Christ Hospital | Cincinnati | Ohio | 45219 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Renal Disease Research Institute | Dallas | Texas | 75235 | — |
| University of Texas Southwestern | Dallas | Texas | 75390 | — |
| University of Wisconsin - Madison | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04225923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04225923 live on ClinicalTrials.gov.